The sharp downturn in startup funding between 2021 and 2022 extends to venture-backed companies working on cancer therapies and diagnostics.
Health, Wellness & Biotech
It was a weird week. Two of the top four rounds were actually large down rounds and a third came with “restructuring” and layoff news. Not exactly...
As we revisit a previously curated list of truly terrible SPAC performers, it’s clear they’re closing out the year at a particularly low point.
MasterControl, a decades old Salt Lake City-based company that provides software to manage the development of life science products, reached unicorn...
HistoSonics raised $85 million in funding led by Johnson & Johnson for a futuristic device it says could demolish tumors in patients with liver...
The current state of flux gives us the rare opportunity to build on telehealth successes.
November was another down month in venture, as VCs continue to pull back in a chilly market. Only three firms made a dozen or more deals, making us...
Pharmaceutical giant Amgen is wrapping 2022 with the largest pharmaceutical acquisition of the year (so far).
Cuban's company circumvented the pharmacy and insurance companies to directly reach customers. Now, it’s going to employers.
Telehealth Startups Pivot (Yet Again) As Employer Benefits Get Reevaluated In Layoff-Looming Economy
As tech companies slash their workforces and tighten their 2023 budgets, employers that once embraced shiny new perks to attract and retain talent...
Last week's launch of OpenAI's writing bot showed us that professional writers are just as replaceable as anyone else, and the sector continues to...
![Illustration of a guy watering plants with a blocked hose - Global [Dom Guzman]](https://news.crunchbase.com/wp-content/uploads/quarterly-global-3-300x168.jpg)
67.1K Followers